MultiCare Valley Hospital
12606 East Mission Ave, Spokane Valley, WA · Multicare · · NPI 1538345251
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj., patisiran, 0.1 mg HCPCS J0222 | not published | not published | $101.84 – $12,661.75 | 14 |
| Inj, pedmark, 100 mg HCPCS J0208 | not published | not published | $96.35 – $4,061.20 | 14 |
| Inj, pegcetacoplan, 1mg HCPCS J2781 | not published | not published | $149.20 – $1,137.14 | 14 |
| Inj pegfilgrastim-bmez 0.5mg HCPCS Q5120 | not published | not published | $34.59 – $3,063.62 | 14 |
| Inj, pegulicianine, 1 mg HCPCS A9615 | not published | not published | $37.86 – $166.92 | 11 |
| Inj. pemetrexed, 10 mg HCPCS J9304 | not published | not published | $8.07 – $4,061.20 | 14 |
| Inj pemetrexed (accord) 10mg HCPCS J9296 | not published | not published | $9.75 – $1,137.14 | 14 |
| Inj, pemetrexed (avyxa) 10mg HCPCS J9292 | not published | not published | $82.79 – $362.10 | 10 |
| Inj pemetrexed (bluepoint) HCPCS J9322 | not published | not published | $10.70 – $1,137.14 | 13 |
| Inj pemetrexed ditromethamin HCPCS J9323 | not published | not published | $7.04 – $1,192.34 | 9 |
| Inj pemetrexed, hospira 10mg HCPCS J9294 | not published | not published | $2.96 – $1,137.14 | 14 |
| Inj pemetrexed (sandoz) 10mg HCPCS J9297 | not published | not published | $1.68 – $1,192.34 | 8 |
| Inj pemetrexed (teva) 10mg HCPCS J9314 | not published | not published | $10.00 – $59.63 | 12 |
| Inj, pemivibart, 4500 mg HCPCS Q0224 | not published | not published | $8,163.54 – $29,296.58 | 4 |
| Inj, pemrydi rtu, 10 mg HCPCS J9324 | not published | not published | $71.14 – $376.87 | 12 |
| Inj peritoneal venous shunt CPT 49427 | $227.20 | $568.00 | $205.44 – $217.53 | 5 |
| Inj., perseris, 0.5 mg HCPCS J2798 | not published | not published | $12.29 – $361.38 | 14 |
| Inj plasminogen tvmh 1mg HCPCS J2998 | not published | not published | $38.75 – $134.92 | 12 |
| Inj., plazomicin, 5 mg HCPCS J0291 | not published | not published | $3.54 – $361.38 | 14 |
| Inj pozelimab-bbfg, 1 mg HCPCS J9376 | not published | not published | $92.59 – $20,769.00 | 11 |
| Inj proc ankle arthr CPT 27648 | $444.80 | $1,112.00 | $205.44 – $217.53 | 5 |
| Inj proc elbow arthro CPT 24220 | $682.00 | $1,705.00 | $205.44 – $217.53 | 5 |
| Inj proc for lymphang CPT 38790 | $682.00 | $1,705.00 | $205.44 – $217.53 | 5 |
| Inj proc lumbr disk ea lvl CPT 62290 | not published | not published | $205.44 – $217.53 | 5 |
| Inj proc myelogram lumbar CPT 62284 | $403.60 | $1,009.00 | $205.44 – $217.53 | 5 |
| Inj proc sialogram CPT 42550 | not published | not published | $205.44 – $217.53 | 5 |
| Inj protirelin per 250 mcg HCPCS J2725 | not published | not published | $30.49 – $56.76 | 2 |
| Inj recombin esperoct per iu HCPCS J7204 | not published | not published | $2.25 – $9.21 | 12 |
| Inj, releuko 1 mcg HCPCS Q5125 | $12.68 | $31.68 | $0.32 – $109.29 | 14 |
| Inj retacrit esrd on dialysi HCPCS Q5105 | $5.39 | $13.46 | $1.02 – $60.12 | 10 |
| Inj retro urethrocysto CPT 51610 | $244.40 | $611.00 | $205.44 – $217.53 | 5 |
| Inj, rimabotulinumtoxinb HCPCS J0587 | not published | not published | $13.41 – $361.38 | 14 |
| Inj roctavian ml 2x10^13vc g HCPCS J1412 | not published | not published | $12,671.72 – $53,434.75 | 11 |
| Inj., rolapitant, 0.5 mg HCPCS J2797 | not published | not published | $1.26 – $114.59 | 7 |
| Inj romidepsin non-lyo 0.1mg HCPCS J9318 | not published | not published | $28.79 – $150.90 | 12 |
| Inj, rykindo, 0.5 mg HCPCS J2801 | not published | not published | $13.15 – $361.38 | 14 |
| Inj scleros sol mult veins CPT 36471 | $442.40 | $1,106.00 | $383.98 – $1,660.16 | 14 |
| Inj scleros sol sgl vein CPT 36470 | $567.60 | $1,419.00 | $383.98 – $1,660.16 | 14 |
| Inj, sculptra, 0.5mg HCPCS Q2028 | not published | not published | $1.40 – $4.54 | 12 |
| Inj sebelipase alfa 1 mg HCPCS J2840 | not published | not published | $545.25 – $2,400.24 | 12 |
| Inj secretin synthetic human HCPCS J2850 | not published | not published | $40.61 – $361.38 | 14 |
| Inj secukinumab intrav 1mg HCPCS J3247 | not published | not published | $18.21 – $1,137.14 | 14 |
| Inj, sezaby, 1 mg HCPCS J2561 | not published | not published | $0.91 – $3.18 | 10 |
| Inj, spesolimab-sbzo, 1 mg HCPCS J1747 | not published | not published | $66.35 – $19,548.35 | 14 |
| Inj(s) sclerosant spider veins limb/trunk CPT 36468 | $245.20 | $613.00 | $383.98 – $1,660.16 | 14 |
| Inj sulf hexa lipid microsph HCPCS Q9950 | $56.24 | $140.59 | not published | 0 |
| Inj, susvimo 0.1 mg HCPCS J2779 | not published | not published | $76.92 – $364.59 | 12 |
| Inj, sutimlimab-jome, 10 mg HCPCS J1302 | not published | not published | $19.83 – $75.69 | 12 |
| Inj. tagraxofusp-erzs 10 mcg HCPCS J9269 | not published | not published | $360.64 – $12,661.75 | 14 |
| Inj, taliglucerace alfa 10 u HCPCS J3060 | not published | not published | $41.04 – $12,661.75 | 14 |
| Inj teclistamab cqyv 0.5 mg HCPCS J9380 | not published | not published | $34.83 – $3,063.62 | 14 |
| Inj tedizolid phosphate HCPCS J3090 | not published | not published | $1.98 – $109.29 | 14 |
| Inj teplizumab mzwv 5 mcg HCPCS J9381 | not published | not published | $38.75 – $161.40 | 12 |
| Inj. teprotumumab-trbw 10 mg HCPCS J3241 | not published | not published | $369.75 – $12,661.75 | 14 |
| Inj, testosterone, azmiro HCPCS J1072 | not published | not published | $0.14 – $5.74 | 10 |
| Inj testosterone cypionate HCPCS J1071 | $0.72 | $1.80 | not published | 0 |
| Inj theophylline per 40 mg HCPCS J2810 | not published | not published | $0.57 – $1.04 | 2 |
| Inj thiotepa nos 1 mg HCPCS J9342 | not published | not published | $5.79 – $54.47 | 10 |
| Inj thrc fascial pln blk bi w/wo image CPT 64468 | not published | not published | $786.86 – $833.14 | 5 |
| Inj thrc fascial pln blk uni w/wo image CPT 64466 | not published | not published | $295.29 – $312.66 | 5 |
| Inj. tigecycline (accord) HCPCS J3244 | not published | not published | $3.98 – $11.79 | 3 |
| Inj., tildrakizumab, 1 mg HCPCS J3245 | not published | not published | $119.31 – $613.34 | 12 |
| Inj, tislelizumab-jsgr HCPCS J9329 | not published | not published | $58.82 – $1,241.15 | 10 |
| Inj tofersen intrathec 1 mg HCPCS J1304 | not published | not published | $161.51 – $652.24 | 12 |
| Inj, tofidence, 1 mg HCPCS Q5133 | not published | not published | $5.31 – $133.20 | 12 |
| Inj travoprost intra impl HCPCS J7355 | not published | not published | $198.73 – $852.53 | 14 |
| Inj triamcinolone ace X-ray 1mg HCPCS J3304 | not published | not published | $18.81 – $361.38 | 14 |
| Inj triferic avnu 0.1mg iron HCPCS J1445 | not published | not published | $0.26 – $0.47 | 2 |
| Inj., triluron, 1 mg HCPCS J7332 | not published | not published | $10.64 – $19.12 | 11 |
| Inj., triptorelin X-ray 3.75 mg HCPCS J3316 | not published | not published | $3,758.76 – $13,970.42 | 14 |
| Inj, trivisc 1 mg HCPCS J7329 | not published | not published | $3.30 – $43.03 | 12 |
| Inj, tyenne, 1 mg HCPCS Q5135 | not published | not published | $4.48 – $246.21 | 13 |
| Inj ustekinumab-aekn, 1 mg HCPCS Q9998 | not published | not published | $11.86 – $212.71 | 10 |
| Inj ustekinumab-kfce, 1 mg HCPCS Q5100 | not published | not published | $3.39 – $24.68 | 10 |
| Inj ustekinumab-stba, 1 mg HCPCS Q5099 | not published | not published | $3.24 – $10.72 | 9 |
| Inj, uzedy, 1 mg HCPCS J2799 | not published | not published | $25.39 – $769.01 | 14 |
| Inj, vancomycin hcl (mylan) HCPCS J3371 | not published | not published | $8.91 – $27.81 | 3 |
| Inj, vancomycin hcl (xellia) HCPCS J3372 | not published | not published | $9.72 – $28.88 | 3 |
| Inj vasopressin (am reg) 1 u HCPCS J2599 | not published | not published | $0.74 – $2.49 | 2 |
| Inj, vasopressin (baxter) HCPCS J2601 | not published | not published | $1.55 – $16.78 | 11 |
| Inj, vegzelma, 10 mg HCPCS Q5129 | not published | not published | $34.98 – $769.01 | 13 |
| Inj velmanase alfa-tycv 1 mg HCPCS J0217 | not published | not published | $469.61 – $1,886.80 | 12 |
| Inj., vestronidase alfa-vjbk HCPCS J3397 | not published | not published | $282.79 – $12,661.75 | 13 |
| Inj. viltolarsen HCPCS J1427 | not published | not published | $64.69 – $261.70 | 3 |
| Inj vocal cord bulking agent HCPCS L8607 | $1,902.80 | $4,757.00 | $61.84 – $61.84 | 1 |
| Inj w/fluor eval cv device CPT 36598 | $435.60 | $1,089.00 | $205.44 – $919.24 | 14 |
| Inj. xembify, 100 mg HCPCS J1558 | not published | not published | $15.51 – $606.07 | 14 |
| Inj xipere 1 mg HCPCS J3299 | not published | not published | $48.23 – $211.86 | 14 |
| Inj., yutiq, 0.01 mg HCPCS J7314 | not published | not published | $534.87 – $4,061.20 | 14 |
| Inj zanidatamab-hrii, 2 mg HCPCS J9276 | not published | not published | $25.00 – $111.61 | 10 |
| Inj zenocutuzumab-zbco 1 mg HCPCS J9382 | not published | not published | $33.57 – $145.16 | 10 |
| Inner skull vessel surgery CPT 61702 | not published | not published | $2,500.00 – $2,500.00 | 1 |
| Inotuzumab ozogamicin 0.9 mg(0.25 mg/ml initial concentration) IV soln HCPCS J9229 | not published | not published | $2,843.24 – $12,661.75 | 14 |
| Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy HCPCS G0459 | not published | not published | $143.11 – $143.11 | 1 |
| Inpt/ed teleconsult30 HCPCS G0425 | not published | not published | $301.36 – $301.36 | 1 |
| Inpt/ed teleconsult50 HCPCS G0426 | not published | not published | $427.20 – $427.20 | 1 |
| Inpt/ed teleconsult70 HCPCS G0427 | not published | not published | $607.59 – $607.59 | 1 |
| Inpt/tele follow up 15 HCPCS G0406 | not published | not published | $133.92 – $133.92 | 1 |
| Inpt/tele follow up 25 HCPCS G0407 | not published | not published | $237.21 – $237.21 | 1 |
| Inpt/tele follow up 35 HCPCS G0408 | not published | not published | $343.14 – $343.14 | 1 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.